Article
Urinary tract effects of HPSE2 mutations.
Journal of the American Society of Nephrology : JASN - 1 Apr 2015
Stuart Helen M, Roberts Neil A, Hilton Emma N, McKenzie Edward A, Daly Sarah B, Hadfield Kristen D, Rahal Jeffery S, Gardiner Natalie J, Tanley Simon W, Lewis Malcolm A, Sites Emily, Angle Brad, Alves Cláudia, Lourenço Teresa, Rodrigues Márcia, Calado Angelina, Amado Marta, Guerreiro Nancy, Serras Inês, Beetz Christian, Varga Rita-Eva, Silay Mesrur Selcuk, Darlow John M, Dobson Mark G, Barton David E, Hunziker Manuela, Puri Prem, Feather Sally A, Goodship Judith A, Goodship Timothy H J, Lambert Heather J, Cordell Heather J, Saggar Anand, Kinali Maria, Lorenz Christian, Moeller Kristina, Schaefer Franz, Bayazit Aysun K, Weber Stefanie, Newman William G, Woolf Adrian S
Abstract excerpt
Urofacial syndrome (UFS) is an autosomal recessive congenital disease featuring grimacing and incomplete bladder emptying. Mutations of HPSE2, encoding heparanase 2, a heparanase 1 inhibitor, occur in UFS, but knowledge about the HPSE2 mutation spectrum is limited. Here, seven UFS kindreds with HPSE2 mutations are presented, including one with deleted asparagine 254, suggesting a role for this amino acid, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
